What is Xilio Therapeutics, Inc. Common Stock's Market Cap?

Xilio Therapeutics, Inc. Common Stock's Market Cap is $49.8M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Price / Sales?

Xilio Therapeutics, Inc. Common Stock's Price / Sales is 0.8×, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Revenue (TTM)?

Xilio Therapeutics, Inc. Common Stock's Revenue (TTM) is $64.1M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Net Income (TTM)?

Xilio Therapeutics, Inc. Common Stock's Net Income (TTM) is -$21.8M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's EBITDA?

Xilio Therapeutics, Inc. Common Stock's EBITDA is -$30.0M, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.32, based on as-reported figures from SEC (XBRL) filings.

What is Xilio Therapeutics, Inc. Common Stock's EBITDA Margin?

Xilio Therapeutics, Inc. Common Stock's EBITDA Margin is -46.9%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Xilio Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00M4D4XC8

7.57▼ 0.46 (-5.73%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value: —
Trailing P/E: —
Price / Sales
EV / Revenue: —
EV / EBITDA: —

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt: —

Trading Information

Previous Close: 8.03
Day's Range: 7.51 – 8.25
52-Week Range: 0.46 – 9.90
Volume: 13.7K
Avg Volume: 11.9K

Share Statistics

Shares Outstanding
Employees: 76
Exchange: XNAS
Listed: 2021-10-22

Share count as of June 30, 2026

Xilio Therapeutics, Inc. Common Stock (XLO) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Xilio Therapeutics, Inc. Common Stock (XLO)

What is Xilio Therapeutics, Inc. Common Stock's Market Cap?: Xilio Therapeutics, Inc. Common Stock's Market Cap is $49.8M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Price / Sales?: Xilio Therapeutics, Inc. Common Stock's Price / Sales is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Revenue (TTM)?: Xilio Therapeutics, Inc. Common Stock's Revenue (TTM) is $64.1M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Net Income (TTM)?: Xilio Therapeutics, Inc. Common Stock's Net Income (TTM) is -$21.8M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's EBITDA?: Xilio Therapeutics, Inc. Common Stock's EBITDA is -$30.0M, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Xilio Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.32, based on as-reported figures from SEC (XBRL) filings.
What is Xilio Therapeutics, Inc. Common Stock's EBITDA Margin?: Xilio Therapeutics, Inc. Common Stock's EBITDA Margin is -46.9%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · XLOAs-filed SEC (XBRL) data